In 2005, a team of researchers led by JA Hellings published a report titled “Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders.” that aimed to determine if Risperdal (risperidone) caused elevated prolactin levels in females more than males.  Elevated prolactin levels (hyperprolactinemia) may result in a number of side effects including gynecomastia and galactorrhea.

The authors write “In this relatively long-term study of risperidone efficacy and safety for aggression and self-injury in children, adolescents, and adults with [mental retardation] and [pervasive developmental disorders], serum prolactin was measured in a 21-subject subset during the course of a double-blind, placebo-controlled trial.”

Results showed that prolactin levels increased in children and adolescents by more than double after taking Risperdal, and prolactin levels increased in adults about eight-fold.  It was indeed determined that females suffered greater prolactin elevation than men.

Sadly, Janssen Pharmaceuticals, Inc., the company that makes Risperdal, has failed time and again to clearly warn its users that Risperdal use is associated with gynecomastia and other serious complications.  As a result, a number of Risperdal lawsuits are currently being filed.

If you or a loved one used Risperdal and suffered gynecomastia or another complication as a result, you too may be entitled to significant financial compensation.  For a free, no-obligation case consultation, contact our team of Risperdal lawyers at the information provided below.  We have the compassion, experience, and resources required to win the justice you deserve.  Call today and see how we can help.

(855) 452 – 5529

Our Risperdal Lawsuit Information page is a great place to start if you have any questions about Risperdal.